Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Meningeal Carcinomatosis × Temozolomide × Clear all

Phase

Status

Terminated 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 186 Gliosarcoma 87 Brain Neoplasms 86 Glioma 77 Central Nervous System Neoplasms 71 Astrocytoma 60 Oligodendroglioma 39 Melanoma 32 Medulloblastoma 16 Neuroblastoma 15 Neoplasm Metastasis 13 Ependymoma 13 Neoplasms 9 Sarcoma 8 Recurrence 8 Choroid Plexus Neoplasms 8 Ovarian Neoplasms 7 Optic Nerve Glioma 7 Familial ependymoma 7 Spinal Cord Neoplasms 6 Sarcoma, Ewing 6 Pinealoma 6 Neuroectodermal Tumors, Primitive 6 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 6 Uveal Melanoma 5 Unspecified Adult Solid Tumor, Protocol Specific 5 Neuroendocrine Tumors 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Lung Neoplasms 5

Interventions

Pemetrexed 4 Dexamethasone 3 osimertinib 2 Vitamin B 12 2 Trastuzumab 2 Topotecan 2 Spinal Puncture 2 Radiotherapy 2 Methotrexate 2 Folic Acid 2 Cytarabine 2 Busulfan 2 Bevacizumab 2 trioctyl phosphine oxide 1 trastuzumab deruxtecan 1 tipifarnib 1 merphos 1 mafosfamide 1 immunotoxin LMB-7 1 epothilone B 1 avelumab 1 Transplantation, Autologous 1 Temozolomide 1 Rituximab 1 Referral and Consultation 1 Radiotherapy, Intensity-Modulated 1 Nivolumab 1 Melphalan 1 Ipilimumab 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02654106 2017-06-06

SRTRBM

ChineseAMS

Phase 2 Completed

Brain Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡